Milestone Scientific INC 10-Q quarterly reports

Milestone Scientific reported stable revenue for Q1 2026, with a decrease in dental sales offset by growth in medical products, while significantly reducing operating expenses.

Milestone Scientific reports continued operating losses in Q3 2025, with a 6% revenue decline driven by lower dental sales, despite re-entry into the China market.

Milestone Scientific reported a net loss of $1.48 million for Q2 2025 and $3.48 million for the six months, with a significant decrease in cash and a going concern warning, despite increased product sales.

Milestone Scientific's Q1 2025 results show stable revenue but increased operating losses due to higher expenses, with management focusing on revenue growth and cost reduction.

Milestone Scientific's Q3 2024 results show a mixed performance with increased revenue offset by continued operating losses, as the company navigates strategic shifts in distribution and product development.

Milestone Scientific's Q2 2024 results show a decrease in revenue compared to the previous year, but also a significant gain from the sale of net operating losses.

Milestone Scientific's first quarter 2024 results show a decrease in revenue compared to the same period last year, alongside a net loss, as the company continues its transition to a commercially focused medical device company.